T-cell immunity in acute coronary syndromes.
暂无分享,去创建一个
R. Frye | D. Holmes | S. Kopecky | C. Weyand | J. Goronzy | G. Liuzzo
[1] Jeffrey L. Anderson,et al. Chronic infection and coronary artery disease. , 2003, Cardiology clinics.
[2] G. Hoffman,et al. Inflammatory Diseases of Blood Vessels , 2001 .
[3] C. Weyand,et al. Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. , 2001, Trends in immunology.
[4] R. Frye,et al. Molecular Fingerprint of Interferon-&ggr; Signaling in Unstable Angina , 2001, Circulation.
[5] A. Vallejo,et al. Functional Disruption of the CD28 Gene Transcriptional Initiator in Senescent T Cells* , 2001, The Journal of Biological Chemistry.
[6] C. Weyand,et al. CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. , 2001, Arthritis and rheumatism.
[7] A. Vallejo,et al. Clonality and Longevity of CD4+CD28null T Cells Are Associated with Defects in Apoptotic Pathways1 , 2000, The Journal of Immunology.
[8] M. Savolainen,et al. Infectious Aspects of Atherosclerosis , 2000 .
[9] W. O'Fallon,et al. T cell homeostasis in patients with rheumatoid arthritis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] C. Hunter,et al. Cytokines and T cells in host defense. , 2000, Current opinion in immunology.
[11] J. Yen,et al. Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis1 , 2000, The Journal of Immunology.
[12] A. Camm,et al. Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence? , 2000, European heart journal.
[13] R. Frye,et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. , 2000, Circulation.
[14] É. Vivier,et al. Regulation of T cell function by NK cell receptors for classical MHC class I molecules. , 2000, Current opinion in immunology.
[15] J. Muhlestein,et al. The ACADEMIC study in perspective (Azithromycin in coronary artery disease: elimination of myocardial infection with Chlamydia). , 2000, The Journal of infectious diseases.
[16] M W Dunne,et al. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial. , 2000, The Journal of infectious diseases.
[17] E. Gurfinkel. Inflammation, infection, or both in atherosclerosis: the ROXIS trial in perspective. , 2000, The Journal of infectious diseases.
[18] J. Darnell,et al. The role of STATs in transcriptional control and their impact on cellular function , 2000, Oncogene.
[19] T. D. Du Clos,et al. Function of C-reactive protein. , 2000 .
[20] R. Biassoni,et al. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. , 2000, Immunology today.
[21] G. Hansson,et al. The Role of Adaptive Immunity in Atherosclerosis , 2000, Annals of the New York Academy of Sciences.
[22] A. Maseri,et al. Inflammation and Acute Coronary Syndromes , 2000, Herz.
[23] A H Davies,et al. The symptomatic carotid plaque. , 2000, Stroke.
[24] Z. Galis. Atheroma morphology and mechanical strength: looks are important, after all--lose the fat. , 2000, Circulation research.
[25] P. Shah. Plaque disruption and thrombosis: potential role of inflammation and infection. , 1999, Cardiology in review.
[26] P. Ridker,et al. C-reactive protein, inflammation, and coronary risk. , 2000, The Medical clinics of North America.
[27] O. Mandelboim,et al. The role of NK cells in innate immunity. , 2000, Advances in experimental medicine and biology.
[28] J. Cyster,et al. Chemokines and cell migration in secondary lymphoid organs. , 1999, Science.
[29] S. Gabriel,et al. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? , 1999, The Journal of rheumatology.
[30] S. Rantapää-Dahlqvist,et al. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. , 1999, The Journal of rheumatology.
[31] V. Pasceri,et al. A tale of two diseases: atherosclerosis and rheumatoid arthritis. , 1999, Circulation.
[32] R. Frye,et al. Perturbation of the T-cell repertoire in patients with unstable angina. , 1999, Circulation.
[33] R. Ross. Atherosclerosis is an inflammatory disease , 1999 .
[34] P. Libby,et al. CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. , 1999, The American journal of pathology.
[35] K. Forfang,et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. , 1999, Circulation.
[36] C. Visser,et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? , 1999, Circulation.
[37] C. Turesson,et al. Extra-articular rheumatoid arthritis: prevalence and mortality. , 1999, Rheumatology.
[38] A. Vallejo,et al. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. , 1999, Journal of immunology.
[39] B. Horne,et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. , 1999, Circulation.
[40] L. Arroyo,et al. Mechanisms of plaque rupture: mechanical and biologic interactions. , 1999, Cardiovascular research.
[41] A E Becker,et al. Atherosclerotic plaque rupture--pathologic basis of plaque stability and instability. , 1999, Cardiovascular research.
[42] A. Newby,et al. Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. , 1999, Cardiovascular research.
[43] J. Hutchcroft,et al. CD28/CTLA-4 and CD80/CD86 families , 1999, Immunologic research.
[44] A. Haase,et al. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. , 1999, Annual review of immunology.
[45] E. Gurfinkel,et al. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study. , 1999, European heart journal.
[46] H. Robenek,et al. Monocytes/macrophages in atherosclerosis. , 1999, European cytokine network.
[47] U. Wagner,et al. Functional subsets of CD4 T cells in rheumatoid synovitis. , 1998, Arthritis and rheumatism.
[48] A. Vallejo,et al. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28- T cells from rheumatoid arthritis patients. , 1998, Journal of immunology.
[49] K. Koch,et al. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes , 1998, Heart.
[50] C. Weyand,et al. Functional properties of CD4+CD28− T cells in the aging immune system , 1998, Mechanisms of Ageing and Development.
[51] A. Vallejo,et al. Aging-related Deficiency of CD28 Expression in CD4+ T Cells Is Associated with the Loss of Gene-specific Nuclear Factor Binding Activity* , 1998, The Journal of Biological Chemistry.
[52] E. Falk,et al. Coronary atherosclerosis: determinants of plaque rupture. , 1998, European heart journal.
[53] P. Libby,et al. Inflammation, the endothelium, and the acute coronary syndromes. , 1998, Journal of cardiovascular pharmacology.
[54] E. Gurfinkel,et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study , 1997, The Lancet.
[55] H. Rittner,et al. Multiple Mechanisms Support Oligoclonal T Cell Expansion in Rheumatoid Synovitis , 1997, Molecular medicine.
[56] D. Schaid,et al. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. , 1997, Arthritis and rheumatism.
[57] C. Weyand,et al. Co‐stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28− T cells , 1997, European journal of immunology.
[58] A. Gori,et al. Acute T-cell activation is detectable in unstable angina. , 1997, Circulation.
[59] D. Fearon,et al. Innate immunity Innate pathways that control acquired immunity , 1997 .
[60] J. Boyle,et al. ASSOCIATION OF CORONARY PLAQUE RUPTURE AND ATHEROSCLEROTIC INFLAMMATION , 1997, The Journal of pathology.
[61] Samin K. Sharma,et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. , 1996, Circulation.
[62] D. Harrison,et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.
[63] C. Weyand,et al. The Repertoire of CD4+ CD28− T Cells in Rheumatoid Arthritis , 1996, Molecular medicine.
[64] P. Carlson,et al. Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. , 1996, Arthritis and rheumatism.
[65] C. Weyand,et al. CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. , 1996, The Journal of clinical investigation.
[66] R. Locksley,et al. The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.
[67] F. Craig,et al. Immunohistochemical characterization of immune cell composition and cytokine receptor expression in human coronary atherectomy tissue. , 1995, Coronary artery disease.
[68] M. Ferguson,et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. , 1995, Circulation.
[69] V. Fuster,et al. Coronary plaque disruption. , 1995, Circulation.
[70] K. Channon,et al. Differential Expression of Tissue Factor Protein in Directional Atherectomy Specimens From Patients With Stable and Unstable Coronary Syndromes , 1995 .
[71] P. Libby,et al. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[72] A. Becker,et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.
[73] A. Henney,et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[74] E. Arbustini,et al. Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic, immunohistochemical, and biochemical study. , 1991, The American journal of cardiology.